Seeyond Vertex Pharmaceuticals Inc Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seeyond holds 8,511 shares of VRTX stock, worth $4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,511

Previous 10,907 21.97%

Holding current value

$4 Million

Previous $3.16 Million 22.2%

% of portfolio

0.24%

Previous 0.38%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $684,680 - $770,266	-2,396 Reduced 21.97%	8,511 $2.46 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $319,559 - $356,553	1,167 Added 11.98%	10,907 $3.16 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $705,584 - $878,527	-3,003 Reduced 23.57%	9,740 $2.74 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $84,139 - $99,168	-380 Reduced 2.9%	12,743 $3.33 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $646,971 - $816,709	3,655 Added 38.6%	13,123 $2.88 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $441,503 - $494,077	-2,434 Reduced 20.45%	9,468 $1.72 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $16,124 - $19,014	-86 Reduced 0.72%	11,902 $2.4 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $16,147 - $18,822	78 Added 0.65%	11,988 $2.58 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $233,714 - $311,705	1,129 Added 10.47%	11,910 $2.81 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $373,760 - $443,132	1,462 Added 15.69%	10,781 $2.93 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $242,391 - $317,985	-1,075 Reduced 10.34%	9,319 $2.71 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $196,174 - $243,349	982 Added 10.43%	10,394 $2.47 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $55,681 - $74,785	-334 Reduced 3.43%	9,412 $2.06 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $765,821 - $861,923	4,607 Added 89.65%	9,746 $1.65 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $102,387 - $118,410	622 Added 13.77%	5,139 $942,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $686,177 - $868,212	4,517 New	4,517 $749,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

222M

Call Options Held

1.65M

Put Options Held

1.37M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account